Physician profile
Frederick E Finger
NPI 1962400861
$73,087.71
in general payments reported to CMS, 2019-2025
5 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $15K · 2021: $10K · 2022: $4,651 · 2023: $323 · 2024: $2,147 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,645.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $55,268.40 | 2019-2022 | |
| Pioneer Surgical Technology, INC. | $8,423.83 | 2020-2022 | |
| Rti Surgical, INC | $6,750.00 | 2021 | |
| Xtant Medical INC | $2,645.48 | 2023-2025 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$111,359.56 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Finger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.